View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
July 6, 2017

Deals this week: Valeant Pharmaceuticals International, ImmunoPrecise Antibodies

Valeant Pharmaceuticals International has announced the sale of its subsidiary Dendreon Pharmaceuticals for $819.9m to Sanpower Group.

Valeant Pharmaceuticals International has announced the sale of its subsidiary Dendreon Pharmaceuticals for $819.9m to Sanpower Group.

The divestiture is part of the Canadian company’s plans to simplify its business and reduce debt.

ImmunoPrecise Antibodies has announced the private placement of four million shares priced at C$1 ($0.77) each to raise C$4m ($3.08m).

ImmunoPrecise is a Canadian-based provider of antibodies that plans to use the funds to acquire U-Protein Express.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU